Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

  1. Roll call- Staff (2 minutes)

  2. Review of Action Items from 

    June 11 teleconference

     May 21 Teleconference– 5 mins

  3. Review of Public Consultations – Olivier – 10 mins 

    Recently Ratified by the ALAC

    None

    Public Comment for Decision

    Study on Technical Use of Root Zone Label Generation Rules  
    Non-Contracted Party House (NCPH) Election Procedures for Board Seat #14  

    Current Statements (ALAC Advice, Comment or Correspondence)

    Public Comment Name

    Public Comment Close

    Status

    Penholder(s)

    CPWG Feedback on NomCom Review Implementation

     

    Note: Not a formal ICANN public comment.

    COMMENT

    Evolving ICANN’s Multistakeholder Model

    Statement version 09 June 2019:

    Image Added

     

    Note: Extension of public comment to Thursday, 13 June 23:59 UTC.

    COMMENT

    Potential ALAC Feedback on EPDP Phase II

     

    Note: Not a formal ICANN public comment.

    DRAFTING

    Process Proposal for Streamlining Organizational Reviews

     

    DRAFTING

    Jonathan Zuck and Olivier Crepin-Leblond to discuss next steps on the public comment; penholder status TBC.
    Evolving the Governance of the Root Server System

     

    DRAFTING

    Bastiaan Goslings to provide initial review of report, penholder status TBC.


  4.  Update on

    Marrakesh meeting activities- Joint NCUC-At-Large ICANN65 outreach: Policy at ICANN demystified

  5. Update Outreach and Engagement FY20

    Strategy   and upcoming Regional Events – OlivierEURALO ALS  Engagement Task Force -  next steps

    Strategy – EURALO ALS Task Force Engagement Taskforce- Yrjo Lansipuro

  6. EURALO By-Laws Task Force Update -

    Olivie

    Olivier

  7. EURALO Elections, Selections appointments 2019- announcement of winners - Olivier

  8. EURALO Hot Topics 2019 - Olivier

  9. ATLAS III Update  - Olivier 

  10. AOB- Sébastien Bachollet

    1. At-Large Review 
    2. ATRT3
    AOB